Gene · 6272
Papers2,809
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,809
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lysosome-Related Diagnostic Biomarkers for Pediatric Sepsis Integrated by Machine Learning. | J Inflamm Res | 2023 | 38034045 | PubTator, text mining | PubMed |
| Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study. | Infect Agent Cancer | 2023 | 38031140 | PubTator, text mining | PubMed |
| A novel program of infiltrative control in astrocytomas: ADAM23 depletion promotes cell invasion by activating γ-secretase complex. | Neurooncol Adv | 2023 | 38024245 | PubTator, text mining | PubMed |
| Development of a diagnostic and risk prediction model for Alzheimer's disease through integration of single-cell and bulk transcriptomic analysis of glutamine metabolism. | Front Aging Neurosci | 2023 | 38020758 | PubTator, text mining | PubMed |
| Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants. | Mol Neurodegener | 2023 | 38017580 | PubTator, text mining | PubMed |
| Role of arachidonic acid metabolism in intervertebral disc degeneration: identification of potential biomarkers and therapeutic targets via multi-omics analysis and artificial intelligence strategies. | Lipids Health Dis | 2023 | 38007425 | PubTator, text mining | PubMed |
| Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis. | Pharmaceuticals (Basel) | 2023 | 38004378 | PubTator, text mining | PubMed |
| IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma? | Life (Basel) | 2023 | 38004369 | PubTator, text mining | PubMed |
| Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation. | Int J Mol Sci | 2023 | 38003290 | PubTator, text mining | PubMed |
| Generation of a Novel SORT1×HER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor. | Int J Mol Sci | 2023 | 38003245 | PubTator, text mining | PubMed |
| Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype. | mBio | 2023 | 37971257 | PubTator, text mining | PubMed |
| Bone marrow stromal cells in Modic type 1 changes promote neurite outgrowth. | Front Cell Dev Biol | 2023 | 37965581 | PubTator, text mining | PubMed |
| Role of inflammation and immunity in vascular calcification: a bibliometric and visual analysis, 2000-2022. | Front Cardiovasc Med | 2023 | 37965089 | PubTator, text mining | PubMed |
| Targeting Progranulin as an Immuno-Neurology Therapeutic Approach. | Int J Mol Sci | 2023 | 37958929 | PubTator, text mining | PubMed |
| Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders. | Int J Mol Sci | 2023 | 37958618 | PubTator, text mining | PubMed |
| Neuron-specific gene NSG1 binds to and positively regulates sortilin ectodomain shedding via a metalloproteinase-dependent mechanism. | J Biol Chem | 2023 | 37949230 | PubTator, text mining | PubMed |
| Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations. | Brain Commun | 2023 | 37946793 | PubTator, text mining | PubMed |
| Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease. | J Am Coll Cardiol | 2023 | 37940228 | PubTator, text mining | PubMed |
| Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier. | Fluids Barriers CNS | 2023 | 37932749 | PubTator, text mining | PubMed |
| TMED10 mediates the trafficking of insulin-like growth factor 2 along the secretory pathway for myoblast differentiation. | Proc Natl Acad Sci U S A | 2023 | 37931110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6272/papers?page=12